Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BioTechHealthX Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1387526045134462978.png) @BioTechHealthX BioTech Health X

BioTech Health X posts on X about upside, momentum, wall street, $cadl the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1387526045134462978/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1387526045134462978/c:line/m:interactions.svg)

- X Week XXXXX +23%
- X Month XXXXX +16%
- X Months XXXXXX +4,265%
- X Year XXXXXX +6,580%

### Mentions: XX [#](/creator/twitter::1387526045134462978/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1387526045134462978/c:line/m:posts_active.svg)

- X Week XX +15%
- X Month XX +39%
- X Months XXX +15,700%
- X Year XXX +5,167%

### Followers: XXX [#](/creator/twitter::1387526045134462978/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1387526045134462978/c:line/m:followers.svg)

- X Week XXX +1.20%
- X Month XXX +5.10%
- X Months XXX +27%
- X Year XXX +32%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1387526045134462978/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1387526045134462978/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1387526045134462978/influence)
---

**Social category influence**
[finance](/list/finance)  XXXXX% [stocks](/list/stocks)  XXXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[upside](/topic/upside) #1286, [momentum](/topic/momentum) #3268, [wall street](/topic/wall-street) #785, [$cadl](/topic/$cadl) 4.44%, [$crsp](/topic/$crsp) #33, [cure for](/topic/cure-for) 4.44%, [crispr](/topic/crispr) 4.44%, [$tvrd](/topic/$tvrd) 2.22%, [$tdoc](/topic/$tdoc) 2.22%, [$185b](/topic/$185b) XXXX%

**Top accounts mentioned or mentioned by**
[@zimmerbiomet](/creator/undefined) [@hcahealthcare](/creator/undefined) [@healthequity](/creator/undefined) [@acadiahealthca1](/creator/undefined) [@halozymeinc](/creator/undefined) [@unitedhealthgrp](/creator/undefined) [@teladochealths](/creator/undefined) [@brightmindsbio](/creator/undefined) [@axsome](/creator/undefined) [@adicetbio](/creator/undefined) [@fibrogeninc](/creator/undefined) [@qualigen](/creator/undefined) [@corcept](/creator/undefined) [@insmed](/creator/undefined) [@bioharvest](/creator/undefined) [@regeneron](/creator/undefined) [@elevancehealths](/creator/undefined) [@argenxglobal](/creator/undefined) [@emergentlabshqs](/creator/undefined) [@labcorps](/creator/undefined)

**Top assets mentioned**
[CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Teladoc Health, Inc. (TDOC)](/topic/$tdoc) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Tarsus Pharmaceuticals, Inc. Common Stock (TARS)](/topic/$tars) [Elevance Health Inc (ELV)](/topic/$elv) [Laboratory Corp. of America Holdings (LH)](/topic/$lh) [Fresenius Medical Care AG & Co. KGaA (FMS)](/topic/$fms) [Molina Healthcare, Inc. (MOH)](/topic/$moh) [Akropolis (AKRO)](/topic/$akro) [ResMed Inc. (RMD)](/topic/$rmd)
### Top Social Posts [#](/creator/twitter::1387526045134462978/posts)
---
Top posts by engagements in the last XX hours

"$TVRD Retail investors own XX% of Tvardi giving them real control as Phase X data nears. Could this be Wall Streets next retail-driven breakout"  
[X Link](https://x.com/BioTechHealthX/status/1977804112512328114) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-13T18:30Z XXX followers, XXX engagements


"$TDOC After its $18.5B Livongo deal @TeladocHealth's new AI system positions it as the leader in next-gen hospital safety and virtual care"  
[X Link](https://x.com/BioTechHealthX/status/1978440534893936950) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-15T12:39Z XXX followers, XXX engagements


"$BMRN Multiple first-in-class therapies fuel consistent cash flow and long-term value for BioMarin Pharmaceutical. Learn about it more here"  
[X Link](https://x.com/BioTechHealthX/status/1979792565974208940) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:11Z XXX followers, XXX engagements


"$DRUG Trading near XXXX% of its 52-week high @brightmindsbio is poised for a major breakout backed by strong fundamentals"  
[X Link](https://x.com/BioTechHealthX/status/1979794979406086239) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:21Z XXX followers, XX engagements


"$SLS Late-stage trial momentum of SELLAS Life Sciences Group fuels buyout speculation from Wall Street. Check this out"  
[X Link](https://x.com/BioTechHealthX/status/1979799146459697432) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:37Z XXX followers, XXX engagements


"$AXSM @axsome reported $150M Q2 revenue with EPS of $XXXX vs $X expected. Strong Auvelity sales drove XX% YoY growth but net loss hit $48"  
[X Link](https://x.com/BioTechHealthX/status/1963968356140318748) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-09-05T14:11Z XXX followers, XXX engagements


"$SPRO Spero Therapeutics shares skyrocketed over XXX% after tebipenem HBr hit efficacy goals in a 1690-patient Phase X trial"  
[X Link](https://x.com/BioTechHealthX/status/1964744452632895645) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-09-07T17:35Z XXX followers, XXX engagements


"$FGEN @FibroGenInc (NASDAQ:FGEN) offloads FibroGen China for $160M extending cash runway into 2027 while focusing on oncology trials"  
[X Link](https://x.com/BioTechHealthX/status/1970023764772745719) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-09-22T07:14Z XXX followers, XX engagements


"$CORT @Corcept has delivered a jaw-dropping 1534% gain in the last decade. With FDA review of relacorilant underway can this stock keep climbing"  
[X Link](https://x.com/BioTechHealthX/status/1973257534648754501) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-01T05:23Z XXX followers, XXX engagements


"$BHST @bioharvest reports XX% annual revenue growth & a forecasted XX% yearly rise for the next X years far outpacing the XXX% industry average"  
[X Link](https://x.com/BioTechHealthX/status/1975613045062901974) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-07T17:23Z XXX followers, XX engagements


"$CADL Analysts see Candel Therapeutics hitting $XXXXXXXX% higher than $5.39on viral immunotherapy breakthroughs led by CAN-2409 and CAN-3110"  
[X Link](https://x.com/BioTechHealthX/status/1976142701239337298) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:28Z XXX followers, XXX engagements


"$CRSP Analysts project massive upside as CRISPR Therapeutics Casgevy becomes the first gene-editing cure for sickle-cell and thalassemia"  
[X Link](https://x.com/BioTechHealthX/status/1976142843384299896) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:29Z XXX followers, XXX engagements


"$CRSP Analysts project massive upside as CRISPR Therapeutics Casgevy becomes the first gene-editing cure for sickle-cell and thalassemia"  
[X Link](https://x.com/BioTechHealthX/status/1976143033772003673) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:29Z XXX followers, XXX engagements


"$REGN The Phase X C-POST trial proved Libtayo cut cancer recurrence risk by XX% yet @Regeneron tumbled 3%. What spooked investors"  
[X Link](https://x.com/BioTechHealthX/status/1976143068140347784) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:29Z XXX followers, XX engagements


"$TARS Tarsus shares jump XXXX% to $XXXXX as XDEMVY racks up $XXX million in first-half 2025 sales one of the fastest-growing eye drop launches"  
[X Link](https://x.com/BioTechHealthX/status/1976143428372086932) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:31Z XXX followers, XXX engagements


"$ELV Trading at just XXXXX forward earnings vs. the industrys XXXX @ElevanceHealth's strategy could offer a major rebound opportunity"  
[X Link](https://x.com/BioTechHealthX/status/1976143799165624453) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:32Z XXX followers, XX engagements


"$ARGX @argenxglobal soared to $XXXXXX fueled by XX% year-over-year revenue growth and record Vyvgart sales. Can the $45B biotech keep its momentum"  
[X Link](https://x.com/BioTechHealthX/status/1976237900292661498) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T10:46Z XXX followers, XX engagements


"$LH With EPS set to jump XX% this year investors see upside for @Labcorp's $19.5B diagnostics empire"  
[X Link](https://x.com/BioTechHealthX/status/1977421022988308755) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-12T17:08Z XXX followers, XX engagements


"$FMS With shares trading around $XX ongoing product recalls & looming reimbursement cuts continue to cloud @Fresenius' recovery outlook"  
[X Link](https://x.com/BioTechHealthX/status/1977421203972444385) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-12T17:08Z XXX followers, XX engagements


"$GALT With belapectin showing a XX% reduction in varices @GalectinGALT targets a massive untapped market with no approved therapies"  
[X Link](https://x.com/BioTechHealthX/status/1977804258608349247) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-13T18:30Z XXX followers, XXX engagements


"$MOH Molina Healthcares shares plunged XXXXX% in XX months after cutting EPS guidance amid soaring medical costs. Is a turnaround possible"  
[X Link](https://x.com/BioTechHealthX/status/1978047106062684517) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:35Z XXX followers, XX engagements


"$AKRO Akero Therapeutics jumps XXXXX% as new clinical data for efruxifermin shows major liver health gains in MASH patients"  
[X Link](https://x.com/BioTechHealthX/status/1978047322513871146) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:36Z XXX followers, XX engagements


"$CADL With $87.2M cash and $130M financing Candel Therapeutics is ready for its first Biologics License Application next year"  
[X Link](https://x.com/BioTechHealthX/status/1978440749445255501) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-15T12:40Z XXX followers, XX engagements


"$RMD With X billion people affected by sleep apnea @Resmed is positioned for explosive growth. See why ResMed is a smart long-term investment"  
[X Link](https://x.com/BioTechHealthX/status/1979794370871386257) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:18Z XXX followers, XX engagements


"$DCTH High-margin model and strong cash position set stage for Delcath Systems' rapid commercial growth. Check this out"  
[X Link](https://x.com/BioTechHealthX/status/1979794493747646468) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:19Z XXX followers, XXX engagements


"$RKDA Arcadia Biosciences financial losses are accelerating despite its stock rally. Heres what Wall Street isnt telling you"  
[X Link](https://x.com/BioTechHealthX/status/1979795161954791501) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:22Z XXX followers, XX engagements


"$SGHT @SightSciences jumps XX% in XX days with $XX billion glaucoma market exposureanalysts see accelerating revenue growth"  
[X Link](https://x.com/BioTechHealthX/status/1979799307621740714) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-19T06:38Z XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioTechHealthX Avatar @BioTechHealthX BioTech Health X

BioTech Health X posts on X about upside, momentum, wall street, $cadl the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX +23%
  • X Month XXXXX +16%
  • X Months XXXXXX +4,265%
  • X Year XXXXXX +6,580%

Mentions: XX #

Mentions Line Chart

  • X Week XX +15%
  • X Month XX +39%
  • X Months XXX +15,700%
  • X Year XXX +5,167%

Followers: XXX #

Followers Line Chart

  • X Week XXX +1.20%
  • X Month XXX +5.10%
  • X Months XXX +27%
  • X Year XXX +32%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance XXXXX% stocks XXXXX% countries XXXX%

Social topic influence upside #1286, momentum #3268, wall street #785, $cadl 4.44%, $crsp #33, cure for 4.44%, crispr 4.44%, $tvrd 2.22%, $tdoc 2.22%, $185b XXXX%

Top accounts mentioned or mentioned by @zimmerbiomet @hcahealthcare @healthequity @acadiahealthca1 @halozymeinc @unitedhealthgrp @teladochealths @brightmindsbio @axsome @adicetbio @fibrogeninc @qualigen @corcept @insmed @bioharvest @regeneron @elevancehealths @argenxglobal @emergentlabshqs @labcorps

Top assets mentioned CRISPR Therapeutics AG (CRSP) Teladoc Health, Inc. (TDOC) BioMarin Pharmaceutical, Inc. (BMRN) Axsome Therapeutics, Inc (AXSM) Corcept Therapeutics Inc. (CORT) Regeneron Pharmaceuticals Inc (REGN) Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Elevance Health Inc (ELV) Laboratory Corp. of America Holdings (LH) Fresenius Medical Care AG & Co. KGaA (FMS) Molina Healthcare, Inc. (MOH) Akropolis (AKRO) ResMed Inc. (RMD)

Top Social Posts #


Top posts by engagements in the last XX hours

"$TVRD Retail investors own XX% of Tvardi giving them real control as Phase X data nears. Could this be Wall Streets next retail-driven breakout"
X Link @BioTechHealthX 2025-10-13T18:30Z XXX followers, XXX engagements

"$TDOC After its $18.5B Livongo deal @TeladocHealth's new AI system positions it as the leader in next-gen hospital safety and virtual care"
X Link @BioTechHealthX 2025-10-15T12:39Z XXX followers, XXX engagements

"$BMRN Multiple first-in-class therapies fuel consistent cash flow and long-term value for BioMarin Pharmaceutical. Learn about it more here"
X Link @BioTechHealthX 2025-10-19T06:11Z XXX followers, XXX engagements

"$DRUG Trading near XXXX% of its 52-week high @brightmindsbio is poised for a major breakout backed by strong fundamentals"
X Link @BioTechHealthX 2025-10-19T06:21Z XXX followers, XX engagements

"$SLS Late-stage trial momentum of SELLAS Life Sciences Group fuels buyout speculation from Wall Street. Check this out"
X Link @BioTechHealthX 2025-10-19T06:37Z XXX followers, XXX engagements

"$AXSM @axsome reported $150M Q2 revenue with EPS of $XXXX vs $X expected. Strong Auvelity sales drove XX% YoY growth but net loss hit $48"
X Link @BioTechHealthX 2025-09-05T14:11Z XXX followers, XXX engagements

"$SPRO Spero Therapeutics shares skyrocketed over XXX% after tebipenem HBr hit efficacy goals in a 1690-patient Phase X trial"
X Link @BioTechHealthX 2025-09-07T17:35Z XXX followers, XXX engagements

"$FGEN @FibroGenInc (NASDAQ:FGEN) offloads FibroGen China for $160M extending cash runway into 2027 while focusing on oncology trials"
X Link @BioTechHealthX 2025-09-22T07:14Z XXX followers, XX engagements

"$CORT @Corcept has delivered a jaw-dropping 1534% gain in the last decade. With FDA review of relacorilant underway can this stock keep climbing"
X Link @BioTechHealthX 2025-10-01T05:23Z XXX followers, XXX engagements

"$BHST @bioharvest reports XX% annual revenue growth & a forecasted XX% yearly rise for the next X years far outpacing the XXX% industry average"
X Link @BioTechHealthX 2025-10-07T17:23Z XXX followers, XX engagements

"$CADL Analysts see Candel Therapeutics hitting $XXXXXXXX% higher than $5.39on viral immunotherapy breakthroughs led by CAN-2409 and CAN-3110"
X Link @BioTechHealthX 2025-10-09T04:28Z XXX followers, XXX engagements

"$CRSP Analysts project massive upside as CRISPR Therapeutics Casgevy becomes the first gene-editing cure for sickle-cell and thalassemia"
X Link @BioTechHealthX 2025-10-09T04:29Z XXX followers, XXX engagements

"$CRSP Analysts project massive upside as CRISPR Therapeutics Casgevy becomes the first gene-editing cure for sickle-cell and thalassemia"
X Link @BioTechHealthX 2025-10-09T04:29Z XXX followers, XXX engagements

"$REGN The Phase X C-POST trial proved Libtayo cut cancer recurrence risk by XX% yet @Regeneron tumbled 3%. What spooked investors"
X Link @BioTechHealthX 2025-10-09T04:29Z XXX followers, XX engagements

"$TARS Tarsus shares jump XXXX% to $XXXXX as XDEMVY racks up $XXX million in first-half 2025 sales one of the fastest-growing eye drop launches"
X Link @BioTechHealthX 2025-10-09T04:31Z XXX followers, XXX engagements

"$ELV Trading at just XXXXX forward earnings vs. the industrys XXXX @ElevanceHealth's strategy could offer a major rebound opportunity"
X Link @BioTechHealthX 2025-10-09T04:32Z XXX followers, XX engagements

"$ARGX @argenxglobal soared to $XXXXXX fueled by XX% year-over-year revenue growth and record Vyvgart sales. Can the $45B biotech keep its momentum"
X Link @BioTechHealthX 2025-10-09T10:46Z XXX followers, XX engagements

"$LH With EPS set to jump XX% this year investors see upside for @Labcorp's $19.5B diagnostics empire"
X Link @BioTechHealthX 2025-10-12T17:08Z XXX followers, XX engagements

"$FMS With shares trading around $XX ongoing product recalls & looming reimbursement cuts continue to cloud @Fresenius' recovery outlook"
X Link @BioTechHealthX 2025-10-12T17:08Z XXX followers, XX engagements

"$GALT With belapectin showing a XX% reduction in varices @GalectinGALT targets a massive untapped market with no approved therapies"
X Link @BioTechHealthX 2025-10-13T18:30Z XXX followers, XXX engagements

"$MOH Molina Healthcares shares plunged XXXXX% in XX months after cutting EPS guidance amid soaring medical costs. Is a turnaround possible"
X Link @BioTechHealthX 2025-10-14T10:35Z XXX followers, XX engagements

"$AKRO Akero Therapeutics jumps XXXXX% as new clinical data for efruxifermin shows major liver health gains in MASH patients"
X Link @BioTechHealthX 2025-10-14T10:36Z XXX followers, XX engagements

"$CADL With $87.2M cash and $130M financing Candel Therapeutics is ready for its first Biologics License Application next year"
X Link @BioTechHealthX 2025-10-15T12:40Z XXX followers, XX engagements

"$RMD With X billion people affected by sleep apnea @Resmed is positioned for explosive growth. See why ResMed is a smart long-term investment"
X Link @BioTechHealthX 2025-10-19T06:18Z XXX followers, XX engagements

"$DCTH High-margin model and strong cash position set stage for Delcath Systems' rapid commercial growth. Check this out"
X Link @BioTechHealthX 2025-10-19T06:19Z XXX followers, XXX engagements

"$RKDA Arcadia Biosciences financial losses are accelerating despite its stock rally. Heres what Wall Street isnt telling you"
X Link @BioTechHealthX 2025-10-19T06:22Z XXX followers, XX engagements

"$SGHT @SightSciences jumps XX% in XX days with $XX billion glaucoma market exposureanalysts see accelerating revenue growth"
X Link @BioTechHealthX 2025-10-19T06:38Z XXX followers, XX engagements

@BioTechHealthX
/creator/twitter::BioTechHealthX